Clinical trial
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation…
NCT00039624 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00039624 |
|---|---|
| Title | Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer |
| Official title | A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | Brachytherapy |
| Enrollment | 12 |
| Start date | Jun 3, 2002 |
| Primary completion | Jul 29, 2004 |
| Completion | Jul 31, 2018 |
| First posted | Jun 7, 2002 |
| Last update posted | Aug 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: